Director Scott Galit Sells 647,342 Shares of Payoneer Global Inc (PAYO)

Director Scott Galit has sold a significant number of shares in Payoneer Global Inc (PAYO, Financial), according to a recent SEC Filing. On March 12, 2024, the insider disposed of 647,342 shares of the company. Payoneer Global Inc is a financial services company that provides online money transfer and digital payment services. The company enables businesses, professionals, and consumers to connect with each other globally and facilitates seamless cross-border payments. Over the past year, Scott Galit has sold a total of 789,134 shares and has not made any purchases of the company's stock. This latest transaction continues the trend of insider selling at Payoneer Global Inc, with a total of 24 insider sells and no insider buys over the past year. 1768130968394297344.png On the day of the sale, shares of Payoneer Global Inc were trading at $4.53, giving the company a market cap of $1.644 billion. The price-earnings ratio of the company stands at 18.58, which is lower than the industry median of 28.11 and also below the company's historical median price-earnings ratio. The stock's price-to-GF-Value ratio is currently at 0.7, with a GF Value of $6.46, indicating that the stock is considered a Possible Value Trap, Think Twice according to GuruFocus' valuation. 1768130985926488064.png The GF Value is calculated based on historical trading multiples, a GuruFocus adjustment factor related to the company's past performance, and future business performance estimates provided by Morningstar analysts.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.